Litcius/Paper detail

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study

Giulio Cavalli, Giacomo De Luca, Corrado Campochiaro, Emanuel Della‐Torre, Marco Ripa, Diana Canetti, Chiara Oltolini, Barbara Castiglioni, Chiara Tassan Din, Nicola Boffini, Alessandro Tomelleri, Nicola Farina, Annalisa Ruggeri, Patrizia Rovere‐Querini, Giuseppe Di Lucca, Sabina Martinenghi, Raffaella Scotti, Moreno Tresoldi, Fabio Ciceri, Giovanni Landoni, Alberto Zangrillo, Paolo Scarpellini, Lorenzo Dagna

2020The Lancet Rheumatology1,005 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAnakinraRetrospective cohort studyPopulationHydroxychloroquineARDSInternal medicineMechanical ventilationCoronavirus disease 2019 (COVID-19)DiseaseLungInfectious disease (medical specialty)Environmental healthCOVID-19 Clinical Research StudiesRespiratory Support and MechanismsAdrenal Hormones and Disorders